High EphA3 expressing ophthalmic trigeminal sensory axons are sensitive to ephrin-A5-Fc: implications for lobe specific axon guidance.
The ophthalmic, maxillary and mandibular axon branches of the trigeminal ganglion provide cutaneous sensory innervation to the vertebrate face. In the chick embryo, the trigeminal ganglion is bilobed, with ophthalmic axons projecting from the ophthalmic lobe, while maxillary and mandibular projections emerge from the maxillomandibular lobe. To date, target tissue specific guidance cues that discriminately guide the axon projections from the two trigeminal ganglion lobes are unknown. EphA receptor tyrosine kinases and ephrin-A ligands are excellent candidates for this process as they are known to mediate axon guidance in the developing nervous system. Accordingly, the expression of EphAs and ephrin-As was investigated at stages 13, 15, 20 of chick embryogenesis when peripheral axons from the trigeminal ganglion are pathfinding. EphA3 is expressed highly in the ophthalmic trigeminal ganglion lobe neurons in comparison to maxillomandibular trigeminal ganglion lobe neurons. Furthermore, from stages 13-20 ephrin-A2 and ephrin-A5 ligands are only localized to the mesenchyme of the first branchial arch (maxillary and mandibular processes), the target fields for maxillomandibular trigeminal ganglion axons. We found that ophthalmic and not maxillomandibular lobe axons were responsive to ephrin-A5-Fc utilizing a substratum choice assay. The implication of these results is that EphA3 forward signaling in ophthalmic sensory axons may be an important mechanism in vivo for lobe specific guidance of trigeminal ganglion ophthalmic projections.
Jayasena
C S
CS
ARC Centre for Molecular Genetics of Development (CMGD), School of Molecular and Biomedical Science, The University of Adelaide, Adelaide, South Australia 5005, Australia.
Flood
W D
WD
Koblar
S A
SA
D000818:Animals; D001369:Axons / Q000187:drug effects / Q000378:metabolism*; D002642:Chick Embryo; D036386:Ephrin-A5 / Q000494:pharmacology*; D020439:Growth Cones / Q000502:physiology; D017403:In Situ Hybridization; D009475:Neurons, Afferent / Q000187:drug effects / Q000378:metabolism*; D009882:Ophthalmic Nerve / Q000166:cytology / Q000254:growth & development / Q000378:metabolism*; D012313:RNA / Q000096:biosynthesis / Q000235:genetics; D036121:Receptor, EphA3 / Q000096:biosynthesis* / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014276:Trigeminal Nerve / Q000166:cytology / Q000254:growth & development / Q000378:metabolism*
D036386:Ephrin-A5; D012313:RNA; D036121:Receptor, EphA3